Page last updated: 2024-09-03

estrone-3-o-sulfamate and 4-methylcoumarin 7-o-sulfamate

estrone-3-o-sulfamate has been researched along with 4-methylcoumarin 7-o-sulfamate in 16 studies

Compound Research Comparison

Studies
(estrone-3-o-sulfamate)
Trials
(estrone-3-o-sulfamate)
Recent Studies (post-2010)
(estrone-3-o-sulfamate)
Studies
(4-methylcoumarin 7-o-sulfamate)
Trials
(4-methylcoumarin 7-o-sulfamate)
Recent Studies (post-2010) (4-methylcoumarin 7-o-sulfamate)
890151704

Protein Interaction Comparison

ProteinTaxonomyestrone-3-o-sulfamate (IC50)4-methylcoumarin 7-o-sulfamate (IC50)
Steryl-sulfataseHomo sapiens (human)0.5489

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (12.50)18.2507
2000's10 (62.50)29.6817
2010's3 (18.75)24.3611
2020's1 (6.25)2.80

Authors

AuthorsStudies
Potter, BV; Purohit, A; Reed, MJ; Woo, LW1
Ahmed, S; James, K1
Auer, M; Bilban, M; Billich, A; Nussbaumer, P1
Ahmed, S; James, K; Owen, CP; Patel, CK; Patel, M2
Ahmed, S; James, K; Owen, CP; Patel, CK; Patel, MB1
Ahmed, S; James, K; Owen, CP; Patel, CK; Sampson, L1
Gräfe, U; Härtl, A; Heinisch, L; Jütten, P; Schumann, W; Ulbricht, H; Werner, W1
Ahmed, S; James, K; Owen, CP; Patel, CK1
Ahmed, S; James, K; Owen, CP1
Ahmed, S; Owen, CP; Patel, CK1
Cecchi, A; Hill, B; Liu, Y; Scozzafava, A; Supuran, CT; Taylor, SD; Vullo, D1
Potter, BV; Thomas, MP1
Daśko, M; Demkowicz, S; Kubiński, K; Masłyk, M; Misiak, M; Przybyłowska, M; Rachon, J; Składanowski, A1
Abduelkarem, AR; Anbar, HS; El-Gamal, MI; Kobeissi, S; Mohammad, M; Ossama, A; Zaraei, SO1
Biernacki, K; Ciupak, O; Daśko, M; Demkowicz, S; Kozak, W; Kubiński, K; Martyna, A; Masłyk, M; Nocentini, A; Rachon, J; Rak, J; Śliwka-Kaszyńska, M; Supuran, CT; Świtalska, M; Wietrzyk, J1

Reviews

1 review(s) available for estrone-3-o-sulfamate and 4-methylcoumarin 7-o-sulfamate

ArticleYear
Sulfamates in drug design and discovery: Pre-clinical and clinical investigations.
    European journal of medicinal chemistry, 2019, Oct-01, Volume: 179

    Topics: Anti-Bacterial Agents; Drug Discovery; Gram-Positive Bacteria; Microbial Sensitivity Tests; Molecular Structure; Sulfonic Acids

2019

Other Studies

15 other study(ies) available for estrone-3-o-sulfamate and 4-methylcoumarin 7-o-sulfamate

ArticleYear
Active site directed inhibition of estrone sulfatase by nonsteroidal coumarin sulfamates.
    Journal of medicinal chemistry, 1996, Mar-29, Volume: 39, Issue:7

    Topics: Binding Sites; Breast Neoplasms; Coumarins; Enzyme Inhibitors; Humans; Microsomes; Placenta; Sulfatases; Sulfonamides; Tumor Cells, Cultured

1996
Derivation of a possible transition-state for the reaction catalysed by the enzyme estrone Sulfatase (ES).
    Bioorganic & medicinal chemistry letters, 1999, Jun-21, Volume: 9, Issue:12

    Topics: Binding Sites; Catalysis; Enzyme Inhibitors; Models, Molecular; Structure-Activity Relationship; Substrate Specificity; Sulfatases

1999
New fluorogenic substrate for the first continuous steroid sulfatase assay.
    Bioorganic & medicinal chemistry letters, 2000, May-01, Volume: 10, Issue:9

    Topics: Arylsulfatases; Chemical Phenomena; Chemistry, Physical; Coumarins; Enzyme Inhibitors; Fluorescent Dyes; Fluorometry; Humans; Kinetics; Recombinant Proteins; Steryl-Sulfatase; Structure-Activity Relationship; Sulfatases

2000
Novel inhibitors of the enzyme estrone sulfatase (ES).
    Bioorganic & medicinal chemistry letters, 2001, Mar-26, Volume: 11, Issue:6

    Topics: Alkanes; Coumarins; Enzyme Inhibitors; Estrone; Inhibitory Concentration 50; Ketones; Mesylates; Sulfatases; Sulfonamides; Sulfonic Acids

2001
Hydrophobicity, a physicochemical factor in the inhibition of the enzyme estrone sulfatase (ES).
    Bioorganic & medicinal chemistry letters, 2001, Sep-17, Volume: 11, Issue:18

    Topics: Chemistry, Physical; Coumarins; Enzyme Inhibitors; Estrone; Inhibitory Concentration 50; Models, Biological; Models, Chemical; Structure-Activity Relationship; Sulfatases; Sulfonamides

2001
Determination and use of a transition state for the enzyme estrone sulfatase (ES) from a proposed reaction mechanism.
    Bioorganic & medicinal chemistry letters, 2001, Dec-03, Volume: 11, Issue:23

    Topics: Catalytic Domain; Coumarins; Enzyme Inhibitors; Estrone; Inhibitory Concentration 50; Models, Molecular; Protein Conformation; Structure-Activity Relationship; Sulfatases; Sulfonamides; Sulfonic Acids

2001
The mechanism of the irreversible inhibition of estrone sulfatase (ES) through the consideration of a range of methane- and amino-sulfonate-based compounds.
    Bioorganic & medicinal chemistry letters, 2002, May-06, Volume: 12, Issue:9

    Topics: Enzyme Inhibitors; Methane; Sulfatases; Sulfonic Acids

2002
A novel type of nonsteroidal estrone sulfatase inhibitors.
    Bioorganic & medicinal chemistry letters, 2002, May-20, Volume: 12, Issue:10

    Topics: Cytosine; Drug Design; Enzyme Inhibitors; Kinetics; Lactones; Naphthacenes; Purines; Quinones; Structure-Activity Relationship; Sulfatases

2002
Design, synthesis and biochemical evaluation of AC ring mimics as novel inhibitors of the enzyme estrone sulfatase (ES).
    Bioorganic & medicinal chemistry letters, 2002, May-20, Volume: 12, Issue:10

    Topics: Coumarins; Drug Design; Enzyme Inhibitors; Kinetics; Models, Molecular; Molecular Conformation; Structure-Activity Relationship; Sulfatases; Sulfonamides; Sulfonic Acids

2002
Inhibition of estrone sulfatase (ES) by derivatives of 4-[(aminosulfonyl)oxy] benzoic acid.
    Bioorganic & medicinal chemistry letters, 2002, Sep-02, Volume: 12, Issue:17

    Topics: Antineoplastic Agents; Benzoates; Humans; Hydrophobic and Hydrophilic Interactions; Inhibitory Concentration 50; Structure-Activity Relationship; Sulfatases

2002
Inhibition of estrone sulfatase (ES) by alkyl and cycloalkyl ester derivatives of 4-[(aminosulfonyl)oxy] benzoic acid.
    Bioorganic & medicinal chemistry letters, 2004, Feb-09, Volume: 14, Issue:3

    Topics: Antineoplastic Agents; Benzoic Acid; Coumarins; Enzyme Inhibitors; Esters; Inhibitory Concentration 50; Structure-Activity Relationship; Sulfatases; Sulfonamides; Sulfonic Acids

2004
Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides.
    Bioorganic & medicinal chemistry letters, 2005, Dec-01, Volume: 15, Issue:23

    Topics: Antigens, Neoplasm; Carbonic Anhydrase I; Carbonic Anhydrase II; Carbonic Anhydrase Inhibitors; Carbonic Anhydrase IX; Carbonic Anhydrase V; Carbonic Anhydrases; Humans; Hydrocarbons, Fluorinated; Isoenzymes; Sulfonamides

2005
Discovery and Development of the Aryl O-Sulfamate Pharmacophore for Oncology and Women's Health.
    Journal of medicinal chemistry, 2015, Oct-08, Volume: 58, Issue:19

    Topics: Animals; Antineoplastic Agents; Aromatase Inhibitors; Breast Neoplasms; Drug Discovery; Endometriosis; Estrone; Female; Humans; Male; Molecular Targeted Therapy; Prostatic Neoplasms; Steryl-Sulfatase; Sulfonic Acids; Tubulin Modulators

2015
Synthesis and biological evaluation of fluorinated N-benzoyl and N-phenylacetoyl derivatives of 3-(4-aminophenyl)-coumarin-7-O-sulfamate as steroid sulfatase inhibitors.
    European journal of medicinal chemistry, 2017, Mar-10, Volume: 128

    Topics: Breast Neoplasms; Coumarins; Enzyme Inhibitors; Female; Halogenation; Humans; Placenta; Pregnancy; Receptors, Estrogen; Steryl-Sulfatase; Structure-Activity Relationship; Sulfonamides; Tumor Cells, Cultured

2017
Development of Sulfamoylated 4-(1-Phenyl-1
    Journal of medicinal chemistry, 2022, 03-24, Volume: 65, Issue:6

    Topics: Animals; Breast Neoplasms; Enzyme Inhibitors; Female; Humans; MCF-7 Cells; Mice; Phenol; Steryl-Sulfatase; Structure-Activity Relationship

2022